By Daniella Parra
Recordati said its net revenue reached 1.743 billion euros for the first nine months of 2024, up 12% year-over-year.
EBITDA was 665.7 million euros, up 11.8%, with a revenue margin of 38.2%, the company said. Adjusted net income grew by 9.5%, it said.
“During the first nine months, we delivered double-digit revenue and profit growth, reflecting the strong performance across the business with more patients benefiting from our therapies,” said CEO Rob Koremans. “These results reflect the continued commitment of all our people, who are instrumental to our success.”
